Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $360.6400 (-2.88%) ($360.2500 - $371.0900) on Wed. May. 4, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.94% (three month average) | RSI | 33 | Latest Price | $360.6400(-2.88%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -1.6% a day on average for past five trading days. | Weekly Trend | REGN declines -4.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(63%) XLV(51%) XBI(47%) IVW(41%) QQQ(41%) | Factors Impacting REGN price | REGN will decline at least -1.47% in a week (0% probabilities). VIXM(-11%) UUP(-8%) TLT(-8%) IPO(-5%) SHY(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.47% (StdDev 2.94%) | Hourly BBV | 0 () | Intraday Trend | -2.5% | | | |
|
Resistance Level | $398.75 | 5 Day Moving Average | $376.9(-4.31%) | 10 Day Moving Average | $389.27(-7.35%) | 20 Day Moving Average | $398.75(-9.56%) | To recent high | -15.6% | To recent low | 0.3% | Market Cap | $38.238b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |